Immunotherapie and Immunology news
A 2025 clinical trial reports the first-ever strength improvement in ALS patients using intranasally delivered MSC exosomes — zero adverse events across 32 treatments.
Read More »A June 2026 study shows that senolytic preconditioning dramatically improves MSC efficacy by removing the SASP factors that suppress tissue repair. Plus: AAT-MSCs reverse diabetes via immune reprogramming, and a phase III MSC trial for meniscal repair reaches completion.
Read More »A 2026 real-world study followed 120 refractory lupus nephritis patients treated with UC-MSCs. Cumulative renal response reached 56.7% at 12 months with low relapse rates and zero severe adverse events. Here’s what clinicians need to know.
Read More »A 36-month clinical trial showed zero adverse events and 57% pain reduction when stem cells were injected into torn rotator cuffs. Here’s what weekend warriors and recreational athletes need to know about MSC therapy for sports injuries.
Read More »The MERIT phase 1 trial published in Cell Reports Medicine shows that intravenous UC-MSC therapy is safe in subacute ischemic stroke, with early NIHSS improvement signals. Here’s what clinicians need to know.
Read More »A 2026 meta-analysis of 15 RCTs shows MSCs cut acute GvHD incidence by 53% and chronic GvHD by 50%. A biomarker-guided trial identifies which transplant patients benefit most — and a cell-free exosome approach may be next.
Read More »Your body’s stem cell population drops dramatically after 40. Here’s what the science says about why we age — and how regenerative medicine is fighting back.
Read More »Discover how mesenchymal stem cell therapy is helping COPD, pulmonary fibrosis, and post-COVID lung damage patients breathe easier — right here in Bangkok, Thailand.
Read More »MSC-derived exosomes are reshaping regenerative medicine — learn how these nano-sized vesicles deliver therapy without the risks of whole-cell transplantation.
Read More »Allogeneic vs autologous MSC therapy — our Bangkok clinic compares clinical outcomes, safety, and what the data really shows about donor cell quality.
Read More »Few areas of biomedical research have generated as much ethical debate as stem cell science. From heated political controversies over embryonic stem cell research to public confusion about what stem cells actually are, the field has been surrounded by misconceptions, misinformation, and genuine ethical complexity. For patients considering stem cell therapy and for the general […]
Read More »